Keywords: |
gene mutation; genetics; mutation; clinical trial; cancer risk; note; united states; gadolinium; nuclear magnetic resonance imaging; magnetic resonance imaging; cancer diagnosis; sensitivity and specificity; breast cancer; echomammography; risk factors; cancer screening; mass screening; editorial; breast neoplasms; risk factor; high risk patient; risk assessment; tumor suppressor gene; mammography; early diagnosis; genes, brca1; genes, brca2; breast tumor; contrast medium; cancer epidemiology; germ-line mutation; humans; human; female; priority journal
|